is oral semaglutide fda approved approves for type 2 diabetes, obesity indication pending | MedCentral posted on the topic Novo Nordisk's weight-loss pill wins

Lilly Zepbound / Mounjaro (tirzepatide) ~21% mean weight loss at ~72 weeks (top dose) Clear superiority vs Wegovy Growing long-term durability data Takeaway: Zepbound remains the benchmark every obesity drug must beat or meaningfully out-differentiate

Animals that are more overweight (>40%) are seen in clinical practice but are not appropriately depicted by descriptions in the existing categories

Discover how microdosing with GLP-1 meds can manage appetite and support blood sugar

Compromised -cell function contributes to type 2 diabetes (T2D) development

These statements have not been evaluated by the FDA

Gamma-aminobutyric acid, or GABA, is a neurotransmitter naturally produced in the brain